Our commitment to maintaining the highest standards spans the entire manufacturing process, from the collection of raw materials, such as pollen, to the manufacture of finished allergy immunotherapy products.
Our products are derived from natural allergen sources such as grass pollen, which are harvested at one of our raw materials production facilities.
After primary purification and quality control, the raw material is subjected to secondary purification into an active pharmaceutical ingredient at production facilities in Denmark, France, Spain and the USA. Here, excipients are added as the final product is formulated as either, injection-based immunotherapy, sublingual drops, or tablets.
Quality control and assurance
Following quality control, the products enter the final stages of the production process – packaging, labelling and distribution. The entire production process is subject to continuous quality assurance in compliance with EU, US and Japanese standards for good manufacturing practice.